These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19221687)

  • 21. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.
    Winkel TA; Hoeks SE; Schouten O; Zeymer U; Limbourg T; Baumgartner I; Bhatt DL; Steg PG; Goto S; Röther J; Cacoub PP; Verhagen HJ; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2010 Jul; 40(1):9-16. PubMed ID: 20385507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease.
    Welten GM; Schouten O; Hoeks SE; Chonchol M; Vidakovic R; van Domburg RT; Bax JJ; van Sambeek MR; Poldermans D
    J Am Coll Cardiol; 2008 Apr; 51(16):1588-96. PubMed ID: 18420103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
    Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
    Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and event-free survival of patients with peripheral arterial disease undergoing prevention of cardiovascular disease.
    Blinc A; Kozak M; Šabovič M; Božič Mijovski M; Stegnar M; Poredoš P; Kravos A; Barbič-Žagar B; Stare J; Pohar Perme M
    Int Angiol; 2017 Jun; 36(3):216-227. PubMed ID: 27332992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation.
    Spronk S; White JV; Ryjewski C; Rosenblum J; Bosch JL; Hunink MG
    J Vasc Surg; 2009 May; 49(5):1217-25; discussion 1225. PubMed ID: 19394551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.
    Al-Omran M
    Vasc Health Risk Manag; 2012; 8():349-55. PubMed ID: 22701328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study).
    Cimminiello C; Arpaia G; Polo Friz H; Boracchi P; Marano G; Spezzigu G; Visonà A
    Vasa; 2015 Sep; 44(5):371-9. PubMed ID: 26317257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
    Bavry AA; Anderson RD; Gong Y; Denardo SJ; Cooper-Dehoff RM; Handberg EM; Pepine CJ
    Hypertension; 2010 Jan; 55(1):48-53. PubMed ID: 19996066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cacoub PP; Abola MT; Baumgartner I; Bhatt DL; Creager MA; Liau CS; Goto S; Röther J; Steg PG; Hirsch AT;
    Atherosclerosis; 2009 Jun; 204(2):e86-92. PubMed ID: 19054514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug treatment of peripheral arterial disease in the elderly.
    Aronow WS
    Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
    Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
    Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factor control and treatment of atherothrombosis. Spain REACH Registry].
    Suárez C; Cairols M; Castillo J; Esmatjes E; Sala J; Llobet X; Palma JC;
    Med Clin (Barc); 2007 Oct; 129(12):446-50. PubMed ID: 17953908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management Strategies for Noncardiac Surgery Following a Coronary Artery Event.
    Whayne TF; Saha SP
    Curr Cardiol Rep; 2018 Jan; 20(1):3. PubMed ID: 29353319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis.
    Reid CM; Ademi Z; Nelson MR; Connor G; Chew DP; Shiel L; Smeath A; De Looze F; Steg PG; Bhatt DL; Liew D;
    Med J Aust; 2012 Feb; 196(3):193-7. PubMed ID: 22339526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.